Postpartum Long-Acting Reversible Contraceptive (LARC) Methods

Measure

Among women aged 15-44 years who had a live birth, the percentage that is provided a LARC method (implants or intrauterine devices or systems (IUD/IUS)) within 3 and 60 days of delivery.

Postpartum Long-Acting Reversible Contraceptive (LARC) Methods, see text-only version below

text-only version

The 60-day period reflects American Congress of Obstetricians and Gynecologists (ACOG) recommendations that women should receive contraceptive care at the 6-week postpartum visit. The 3-day period reflects recent Centers for Disease Control and Prevention (CDC) and ACOG recommendations that the immediate postpartum period (i.e. at delivery, while the woman is in the hospital) is a safe and particularly effective time to provide contraception, which may offer greater convenience to the client and avoid missed opportunities to provide contraceptive care, especially considering that many women do not attend a postpartum visit.

How the Measure Should be Used

The Contraceptive Care – Postpartum Access to LARC measure should be used as an access measure; very low rates (less than 1-2% use) may signal barriers to LARC provision that should be addressed through training and quality improvement processes. The barriers to obtaining LARC are well documented, and include client and physician lack of knowledge, financial constraints, and logistical issues. The Contraceptive Care – Postpartum Access to LARC measure should NOT be used to encourage high rates of use as this may lead to coercive practices. This is especially important given the historical context of coercive practices related to contraception. For this reason, it is not appropriate to use this measure in a pay-for-performance context.

Measure specifications and SAS code have been developed to calculate the measures using administrative claims data:

Content is undergoing 508 review and will be updated pending remediation. For immediate assistance, please contact: opa@hhs.gov.